18554627. GENE THERAPY FOR NEUROPROTECTION simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
GENE THERAPY FOR NEUROPROTECTION
Organization Name
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor(s)
Derek S. Welsbie of La Jolla CA (US)
Cassidy D. Lee of La Jolla CA (US)
Amit K. Patel of La Jolla CA (US)
GENE THERAPY FOR NEUROPROTECTION - A simplified explanation of the abstract
This abstract first appeared for US patent application 18554627 titled 'GENE THERAPY FOR NEUROPROTECTION
The abstract describes methods and compounds for treating and preventing neural cell death, including retinal ganglion cell death, as well as nerve degeneration, with potential applications in treating or preventing glaucoma.
- Methods and compounds for treating and preventing neural cell death
- Methods and compounds for treating and preventing nerve degeneration
- Potential application in treating or preventing glaucoma
- Potential Applications:**
The technology can be applied in the treatment and prevention of neural cell death, nerve degeneration, and specifically in the context of glaucoma.
- Problems Solved:**
This technology addresses the critical issue of neural cell death and nerve degeneration, particularly in conditions like glaucoma where these processes can lead to vision loss.
- Benefits:**
The benefits of this technology include the potential to preserve neural cells, prevent nerve degeneration, and ultimately protect vision in patients with conditions like glaucoma.
- Commercial Applications:**
The technology could have significant commercial applications in the pharmaceutical industry for developing new treatments for neurodegenerative diseases like glaucoma, potentially leading to improved patient outcomes and quality of life.
- Questions about Neural Cell Death and Nerve Degeneration:**
1. How do neural cell death and nerve degeneration impact conditions like glaucoma? 2. What are the potential long-term effects of preventing neural cell death and nerve degeneration in patients with glaucoma?
- Frequently Updated Research:**
Researchers are continually exploring new compounds and methods for treating neural cell death and nerve degeneration, with a focus on improving outcomes for patients with conditions like glaucoma.
Original Abstract Submitted
Provided herein, inter alia, are methods and compounds for treating and preventing neural cell death, e.g., retinal ganglion cell death. Also provided herein, inter alia, are methods and compounds for treating and preventing nerve degeneration. The methods and compounds provided herein may treat or prevent glaucoma.